Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 7
2004 3
2005 1
2006 5
2007 10
2008 3
2009 8
2010 5
2011 6
2012 6
2013 5
2014 6
2015 7
2016 6
2017 5
2018 2
2019 4
2020 12
2021 15
2022 8
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean shi ming yu (14 results)?
Platinum-based chemotherapy for variant castrate-resistant prostate cancer.
Aparicio AM, Harzstark AL, Corn PG, Wen S, Araujo JC, Tu SM, Pagliaro LC, Kim J, Millikan RE, Ryan C, Tannir NM, Zurita AJ, Mathew P, Arap W, Troncoso P, Thall PF, Logothetis CJ. Aparicio AM, et al. Among authors: tu sm. Clin Cancer Res. 2013 Jul 1;19(13):3621-30. doi: 10.1158/1078-0432.CCR-12-3791. Epub 2013 May 6. Clin Cancer Res. 2013. PMID: 23649003 Free PMC article.
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial.
Corn PG, Heath EI, Zurita A, Ramesh N, Xiao L, Sei E, Li-Ning-Tapia E, Tu SM, Subudhi SK, Wang J, Wang X, Efstathiou E, Thompson TC, Troncoso P, Navin N, Logothetis CJ, Aparicio AM. Corn PG, et al. Among authors: tu sm. Lancet Oncol. 2019 Oct;20(10):1432-1443. doi: 10.1016/S1470-2045(19)30408-5. Epub 2019 Sep 9. Lancet Oncol. 2019. PMID: 31515154 Free PMC article. Clinical Trial.
Postacute Care in Cancer Rehabilitation.
Guo Y, Fu JB, Guo H, Camp J, Shin KY, Tu SM, Palmer LJ, Yadav R. Guo Y, et al. Among authors: tu sm. Phys Med Rehabil Clin N Am. 2017 Feb;28(1):19-34. doi: 10.1016/j.pmr.2016.09.004. Phys Med Rehabil Clin N Am. 2017. PMID: 27912997 Review.
Managing seminomatous and nonseminomatous germ cell tumors.
Chahoud J, Zhang M, Shah A, Lin SH, Pisters LL, Tu SM. Chahoud J, et al. Among authors: tu sm. Curr Opin Oncol. 2018 May;30(3):181-188. doi: 10.1097/CCO.0000000000000446. Curr Opin Oncol. 2018. PMID: 29538040 Review.
Prostate cancer stem cells.
Tu SM, Lin SH. Tu SM, et al. Clin Genitourin Cancer. 2012 Jun;10(2):69-76. doi: 10.1016/j.clgc.2012.01.002. Epub 2012 Mar 14. Clin Genitourin Cancer. 2012. PMID: 22421313 Free PMC article. Review.
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
El Zarif T, Nassar AH, Pond GR, Zhuang TZ, Master V, Nazha B, Niglio S, Simon N, Hahn AW, Pettaway CA, Tu SM, Abdel-Wahab N, Velev M, Flippot R, Buti S, Maruzzo M, Mittra A, Gheeya J, Yang Y, Rodriguez PA, Castellano D, de Velasco G, Roviello G, Antonuzzo L, McKay RR, Vincenzi B, Cortellini A, Hui G, Drakaki A, Glover M, Khaki AR, El-Am E, Adra N, Mouhieddine TH, Patel V, Piedra A, Gernone A, Davis NB, Matthews H, Harrison MR, Kanesvaran R, Giudice GC, Barata P, Farolfi A, Lee JL, Milowsky MI, Stahlfeld C, Appleman L, Kim JW, Freeman D, Choueiri TK, Spiess PE, Necchi A, Apolo AB, Sonpavde GP. El Zarif T, et al. Among authors: tu sm. J Natl Cancer Inst. 2023 Dec 6;115(12):1605-1615. doi: 10.1093/jnci/djad155. J Natl Cancer Inst. 2023. PMID: 37563779
Optimizing the diagnosis and management of ductal prostate cancer.
Ranasinghe W, Shapiro DD, Zhang M, Bathala T, Navone N, Thompson TC, Broom B, Aparicio A, Tu SM, Tang C, Davis JW, Pisters L, Chapin BF. Ranasinghe W, et al. Among authors: tu sm. Nat Rev Urol. 2021 Jun;18(6):337-358. doi: 10.1038/s41585-021-00447-3. Epub 2021 Apr 6. Nat Rev Urol. 2021. PMID: 33824525 Review.
The Cancer Genome: Paradigm or Paradox?
Tu SM. Tu SM. Cancers (Basel). 2021 Feb 8;13(4):674. doi: 10.3390/cancers13040674. Cancers (Basel). 2021. PMID: 33567511 Free PMC article.
123 results